Kounis Syndrome: Is Ceftriaxone or Metronidazole Responsible for Acute Myocardial Infarction? A Rare Case

Overview

Journal Anatol J Cardiol

Publisher Kare Publishing

Specialty Cardiology & Vascular Diseases

Date 2021 Jun 8

PMID 34100733

Citations 3

Authors

Abdulkadir Cakmak

Gokhan Keskin

Affiliations

Soon will be listed here.

Citing Articles

Kounis Syndrome: Review of Clinical Cases.

Yakushin S, Gurbanova A, Pereverzeva K Cardiovasc Hematol Disord Drug Targets. 2024; 24(2):83-97.

PMID: 39021170 DOI: 10.2174/011871529X305833240708051508.

Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity.

Navarro-Navajas A, Casallas I, Isaza D, Ortiz P, Baracaldo-Santamaria D, Calderon-Ospina C Medicina (Kaunas). 2022; 58(7).

PMID: 35888574 PMC: 9317000. DOI: 10.3390/medicina58070855.

Analysis of Clinical Features of Kounis Syndrome Induced by Cephalosporin.

Fang W, Song L, Deng Z, Sun W, Li Z, Wang C Front Cardiovasc Med. 2022; 9:885438.

PMID: 35557534 PMC: 9086825. DOI: 10.3389/fcvm.2022.885438.

References

Kounis N, Koniari I, Velissaris D, Tzanis G, Hahalis G . Kounis Syndrome—not a Single-organ Arterial Disorder but a Multisystem and Multidisciplinary Disease. Balkan Med J. 2019; 36(4):212-221. PMC: 6636655. DOI: 10.4274/balkanmedj.galenos.2019.2019.5.62. View

Biteker M . A new classification of Kounis syndrome. Int J Cardiol. 2010; 145(3):553. DOI: 10.1016/j.ijcard.2010.05.020. View

Hasegawa S, Tashiro N, Matsubara T, Furukawa S, Ra C . A comparison of FcepsilonRI-mediated RANTES release from human platelets between allergic patients and healthy individuals. Int Arch Allergy Immunol. 2001; 125 Suppl 1:42-7. DOI: 10.1159/000053852. View

Biteker M . Current understanding of Kounis syndrome. Expert Rev Clin Immunol. 2010; 6(5):777-88. DOI: 10.1586/eci.10.47. View

Saleh A . Kounis syndrome: acute inferior myocardial infarction with atroventricular node block due to ceftriaxone: a first reported case. Ann Saudi Med. 2014; 34(3):250-3. PMC: 6074592. DOI: 10.5144/0256-4947.2014.250. View